Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
Titel:
Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
Auteur:
Hutson, Thomas E Lesovoy, Vladimir Al-Shukri, Salman Stus, Viktor P Lipatov, Oleg N Bair, Angel H Rosbrook, Brad Chen, Connie Kim, Sinil Vogelzang, Nicholas J